Shufen Xiang - 1PersonGen BioTherapeutics Co., Ltd

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract 5254: The “off-the-shelf ”CD19-CAR-Vδ1T cells demonstrated an enhanced therapeutic effect on B-cell malignancy models

Dan Chen,Fengtao You, Cheng Chen,Shufen Xiang,Ping Zhang,Hai Wu, Zhong Zheng, Min Wang,Xingbing Wang,Huimin Meng,Nan Yang,Bozhen Zhang,Lin Yang

Cancer Researchno. 6_Supplement (2024): 5254-5254

Cited0Views0Bibtex

A B7-H3-CAR-modified V Δ 1 T Cells Showed Potentanti-Solid Tumor Potential

Licui Jiang, Changsong Qi,Fengtao You,Shufen Xiang,Ping Zhang,Min Wang,Hai Wu, Kunmin Yan, Jiequn Huang, Huimin Meng,Nan Yang,Shirley Zhang,Lin Shen,Lin Yang

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Figure S6 from B7-H3–Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity Against Solid Tumors

Licui Jiang, Fengtao You,Hai Wu, Changsong Qi,Shufen Xiang,Ping Zhang, Huimin Meng,Min Wang, Jiequn Huang, Yafen Li, Dan Chen, Gangli An,Nan Yang, Bozhen Zhang,Lin Shen,Lin Yang

crossref（2024）

Cited0Views0Bibtex

Abstract 5255: A B7-H3-CAR-modified Vδ1 T Cells Showed Potentanti-Solid Tumor Potential

Licui Jiang,Changsong Qi,Fengtao You,Shufen Xiang,Ping Zhang, Min Wang,Hai Wu, Kunmin Yan, Jiequn Huang,Huimin Meng,Nan Yang,Shirley Zhang,Lin Shen,Lin Yang

Cancer Researchno. 6_Supplement (2024): 5255-5255

Cited0Views0Bibtex

B7-H3-Targeted CAR-Vδ1T Cells Exhibit Potent Broad-Spectrum Activity Against Solid Tumors

Licui Jiang,Fengtao You,Hai Wu,Changsong Qi,Shufen Xiang,Ping Zhang,Huimin Meng,Min Wang, Jiequn Huang,Yafen Li,Dan Chen,Gangli An,Nan Yang,Bozhen Zhang,Lin Shen,Lin Yang

Cancer Research (2024)

Cited0Views0WOSBibtex

Enhanced Efficacy of CD19/CD22 Bispecific CAR-T Cells with EAAAK Linker on B-cell Malignancies

Renyuxue Ma,Fengtao You,Shuaiyu Tian,Tingting Zhang,Xiaopeng Tian,Shufen Xiang,Hai Wu,Nan Yang,Gangli An,Lin Yang

European Journal Of Haematology（2023）

Cited1Views0WOSBibtex

MUC1-Tn-targeting Chimeric Antigen Receptor-Modified Vγ9Vδ2 T Cells with Enhanced Antigen-Specific Anti-Tumor Activity

Xiaochen Zhai,Fengtao You,Shufen Xiang,Licui Jiang,Dan Chen,Yafen Li,Shuangshuang Fan,Zhichao Han,Tingting Zhang,Gangli An,Bozhen Zhang,Yusheng Chen,Huimin Meng,Lin Yang

American Journal of Cancer Research（2021）

Cited4Views0WOSBibtex

Chimeric Antigen Receptor T Cells Derived from CD7 Nanobody Exhibit Robust Antitumor Potential Against CD7-positive Malignancies

Dan Chen,Fengtao You,Shufen Xiang,Yinyan Wang,Yafen Li,Huimin Meng,Gangli An,Tingting Zhang,Zixuan Li,Licui Jiang,Hai Wu,Binjie Sheng,Bozhen Zhang,Lin Yang

PubMed（2021）

Cited2Views0WOSBibtex

Novel Anti-Gd2 CAR-T Cells Exhibit Superior Cytotoxicity Against Neuroblastoma

Cheng Ji,Fengtao You,Tingting Zhang,Shuangshuang Fan,Zhichao Han,Shufen Xiang,Yinyan Wang,Binjie Sheng,Tian Wang,Gangli An,Huimin Meng,Lin Yang

European journal of inflammation（2020）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn